Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comparison of Injected Insulin Replacement Therapy With A Novel Transdermally Delivered Human Insulin Product

NCT03544996 is registered in ClinicalTrials.gov with Transdermal Delivery Solutions Corp as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03544996 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comparison of Injected Insulin Replacement Therapy With A Novel Transdermally Delivered Human Insulin Product
Lead sponsor
Transdermal Delivery Solutions Corp
Phase
Observational
Overall status
Completed
Start date
September 9, 2017
Completion date
February 4, 2018
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypoinsulinemia